Kahle KT, Barnett SM, Sassower KC, Staley KJDecreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. J Child Neurol. 2009;24:572-576.
2.
Ben Ari Y., Gaiarsa JL, Tyzio R., Khazipov R.GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev . 2007;87:1215-1284.
3.
DzhalaVI,TalosDM,SdrullaDA,etal. NKCC1transporterfacilitates seizures in the developing brain. Nat Med. 2005;11:1205-1213.
4.
Vanhatalo S., Hellström-Westas L., De Vries LSBumetanide for neonatal seizures: based on evidence or enthusiasm?Epilepsia. 2009;50:1292-1293.
5.
Lopez-Samblas AM, Adams JA, Goldberg RN, Modi MWThe pharmacokinetics of bumetanide in the newborn infant. Biol Neonat. 1997;72:265-272.
6.
Javaheri S., Davis C., Rogers DHIonic composition of cisternal CSF in acute respiratory acidosis: lack of effect of large dose bumetanide. J Neurochem. 1993;61:1525-1529.
7.
Zimmermann A. , Domoki F., Bari F.Seizure-induced alterations in cerebrovacular function in the neonate. Dev Neurosci. 2008 ;30:293-305.
8.
Merkus Fwhm, van den Berg MPCan nasal drug delivery bypass the blood-brain barrier? Questioning the direct transport theory. Drugs R D. 2007;8:133-144.
9.
Chabwine JN, Talavera K., Verbeert L., et al. Differential contribution of the Na+-K+-2Cl- cotransporter to chloride handling in rat embryonic dorsal root ganglion neurons and motor neurons. FASEB J. 2009;23:1168-1176.
10.
Viberg H., Ponten E., Eriksson P., Gordh T., et al. Neonatal ketamine exposure results in changes in biochemical substrates of neuronal growth and synaptogenesis, and alters adult behavior irreversibly. Toxicology. 2008;249:153-159.
